BioCryst Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

BioCryst Pharmaceuticals

26/02/2024 15:19

* BioCryst Pharmaceuticals Inc  BCRX.OQ  reported a
quarterly
adjusted loss of 31 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -38 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 24 cents per
share. Wall Street expected results to range from -38 cents
to -14 cents per share.
    * Revenue rose 17.4% to $93.40 million from a year ago;
analysts
expected $90.01 million. 
    * BioCryst Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 31 cents​.
    * The company reported a quarterly loss of $61.73 million.
    * BioCryst Pharmaceuticals Inc shares had fallen by 4.7%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for BioCryst
Pharmaceuticals Inc is $11.00 
This summary was machine generated from LSEG data February 26 at
03:19 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.24          -0.31          Missed
 Sep. 30 2023      -0.23          -0.19          Beat
 Jun. 30 2023      -0.23          -0.24          Missed
 Mar. 31 2023      -0.30          -0.28          Beat